Atlas Trials

Locoregional Therapy Combined With Bevacizumab and PD1/L1 Inhibitor in Advanced Hepatocellular Carcinoma

Clinical trial NCT06323382 · RECRUITING

Trial details

NCT number
NCT06323382
Sponsor
Sun Yat-sen University
Status
RECRUITING
Study type
OBSERVATIONAL
Advanced Hepatocellular CarcinomaAnti-PD1/PDL1 AntibodyBevacizumab
Start date
2021-01-01
Primary completion
2025-12-30
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.